Immune cell infusion aims to free ARDS patients from ventilators
NCT ID NCT07706855
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests an experimental therapy called GKL-006RTU, made from a type of immune cell (iNKT cells), for people with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. The trial has two parts: first, a small group receives the cell infusion to check safety; then, a larger group is randomly assigned to receive either the cell therapy or a placebo, both added to standard care. The main goal is to see if the treatment helps patients spend fewer days on a ventilator.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental iNKT cell therapy called GKL-006RTU
- What this could lead to
- If successful, this could lead to a new treatment that helps people with severe ARDS recover faster and spend less time on a ventilator.
- What could go wrong
- This is an early-phase trial with only 52 participants, so results may not apply broadly. Cell therapies can cause serious side effects like immune reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New ventilation strategy aims to reduce lung damage in severe pneumonia
- Scientists build a biobank to decode ARDS and personalize treatment
- Scientists hunt for hidden ARDS subtypes to crack deadly lung failure
- Simple chest squeeze may replace High-Tech ventilator settings
- Lab study hopes to unlock ARDS treatment using patient blood cells
- New study uses imaging to see how nitric oxide helps ARDS lungs